Treace to Present at 44th Annual J.P. Morgan Healthcare Conference

Core Viewpoint - Treace Medical Concepts, Inc. is set to present at the 44th Annual J.P. Morgan Healthcare Conference, highlighting its innovative approach in the surgical treatment of bunions and related midfoot deformities [1] Group 1: Company Overview - Treace Medical Concepts is a medical technology company focused on improving surgical management standards for bunions and midfoot deformities, which affect approximately 67 million Americans [4] - The company estimates that 1.1 million Americans are annual surgical candidates for bunion treatment [4] - Treace has developed the patented Lapiplasty 3D Bunion Correction System, which addresses the root cause of bunions by correcting deformities in all three planes and stabilizing the affected joint [4] Group 2: Product Offerings - In addition to the Lapiplasty system, Treace offers the Adductoplasty Midfoot Correction System for midfoot deformities and two minimally invasive osteotomy systems: the Nanoplasty 3D and the Percuplasty™ systems [4] - The company also provides the SpeedMTP MTP Fusion System and is expanding its SpeedPlate rapid compression implant platform for new applications [4] - Treace enhances surgical planning with its IntelliGuide™ technology, which offers patient-specific pre-operative planning and cut guide solutions [4] Group 3: Investor Relations - Treace encourages investors to regularly check its website for important updates and information [3] - A live webcast of the upcoming presentation will be available on the company's investor relations website [2]